SDHA NM_004168.4(SDHA):c.667del (p.Asp223fs)

CI-VAR-00023694Explore in graph →p.Asp223fsNM_004168.4:c.667delClinVar 141876 rs587782077

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
141876	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	2	Hereditary cancer-predisposing syndrome; Pheochromocytoma/paraganglioma syndrome 5; Mitochondrial complex II deficiency, nuclear type 1; Dilated cardiomyopathy 1GG; SDHA-related disorder; Neurodegeneration with ataxia and late-onset optic atrophy	germline	13	Feb 24, 2026	clinvar